EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • March 8th, 2010 • Threshold Pharmaceuticals Inc • Pharmaceutical preparations • New York
This Exclusive License Agreement (this “Agreement”) is made effective as of October 5, 2009 (the “Effective Date”), by and between Threshold Pharmaceuticals, Inc., a Delaware corporation with a principal place of business at 1300 Seaport Boulevard, Suite 500, Redwood City, CA 94063 (“Licensor”), and Eleison Pharmaceuticals, Inc., a Delaware corporation with a place of business at 103 Carnegie Center, Suite 300, Princeton, NJ 08540 (“Licensee”). Licensor and Licensee are each hereafter referred to individually as a “Party” and together as the “Parties”.
